Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04248374 · ClinicalTrials.gov registry record · NA
Fatty Acid Taste Rating With or Without Sour Taste Adaptation
A NA study, sponsored by Purdue University.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
NCT04248374: Completed NA study, sponsored by Purdue University.
NCT04248374 is a NA study that has completed, run by Purdue University. The registered enrollment target is 38 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04248374, a NA study, has completed, sponsored by Purdue University.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
Study Summary
We are trying to figure out whether the fatty acid taste is differentiated from sour taste.
Primary Outcome
two sets of taste intensity ratings without (Test A) or with (Test B) sour taste adaptation. For test A, participants will taste one of the eight solutions or one of solid fatty acids, and rate its intensity before and after expectorating it.
Interventions
- OTHER Taste Intensity
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2019-10-07 |
| Est. Completion | 2020-12-30 |
| Phase | NA |
What the finished NCT04248374 record still lists
NCT04248374 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 38 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which Taste Intensity is the first listed.
NCT04248374 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04248374 about?
NCT04248374 is a clinical study titled "Fatty Acid Taste Rating With or Without Sour Taste Adaptation". We are trying to figure out whether the fatty acid taste is differentiated from sour taste.
What is the current status of trial NCT04248374?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2019-10-07. Estimated completion is 2020-12-30.
What interventions are being tested in trial NCT04248374?
The interventions under investigation include: Taste Intensity (OTHER).
Who is sponsoring clinical trial NCT04248374?
This trial is sponsored by Purdue University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04248374's enrollment target sits among peer trials
38 1538th of 2000 higher than 461 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI